Latest Period
Q1 2026
Security Snapshot
Cogent Biosciences, Inc. - Common Stock (COGT) Institutional Ownership
CUSIP: 19240Q201
13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026
Institutions Reporting
303
Shares (Excl. Options)
186,329,144
Price
$38.49
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- COGT on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 186,329,144
- Total 13F value
- $7,169,925,579
- Portfolio coverage rank
- 0.02%
- Share change
- +7,940,678
- Value change
- +$317,717,543
- Number of holders
- 303
- Shares outstanding
- 170,962,250
- SEC-reported price per share
- $37.25
- Insider filing price
- $37.25
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- COGT - Cogent Biosciences, Inc. - Common Stock is tracked under CUSIP 19240Q201.
- 303 institutions reported positions in Q1 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 266 to 303 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $6,184,105,170 to $7,169,925,579.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 303 institutions filings for Q1 2026.
Security key
19240Q201
Latest holder period
Q1 2026
13F holders
303
13D/G owners
10
CIK / CUSIP context first
Open Q1 2026 holders
COGT full holder history
Cogent Biosciences, Inc. SEC filings
Cogent Biosciences, Inc. company facts
Cogent Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 19240Q201:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
COGT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | $81,355,047 | 16,569,256 | FMR LLC | 31 Dec 2024 | |||
| Fairmount Funds Management LLC | 8.6% | -13% | $542,559,913 | -$31,973,650 | 15,356,918 | -5.6% | Fairmount Funds Management LLC | 31 Mar 2026 |
| BlackRock, Inc. | 6.5% | $403,870,356 | 11,370,224 | BlackRock, Inc. | 31 Dec 2025 | |||
| Flynn James E | 5.3% | -20% | $348,099,826 | -$354,685 | 9,043,903 | -0.1% | Deerfield Mgmt, L.P. | 31 Mar 2026 |
| TCG Crossover GP I, LLC | 4.8% | $97,621,606 | 6,798,162 | TCG Crossover GP I, LLC | 30 Sep 2025 | |||
| Kynam Capital Management, LP | 4.3% | -20% | $219,296,982 | -$61,214,156 | 6,165,223 | -22% | Kynam Capital Management, LP | 31 Dec 2025 |
| Point72 Asset Management, L.P. | 4% | -52% | $82,625,042 | -$60,775,814 | 5,753,833 | -42% | Point72 Asset Management, L.P. | 30 Sep 2025 |
| Venrock Healthcare Capital Partners II, L.P. | 4.2% | -27% | $44,463,093 | -$15,815,581 | 4,755,411 | -26% | Venrock Healthcare Capital Partners II, L.P. | 30 Jun 2025 |
| Paradigm Biocapital Advisors LP | 2.3% | -76% | $45,325,875 | -$103,335,292 | 3,156,398 | -70% | Paradigm BioCapital Advisors LP | 30 Sep 2025 |
| Commodore Capital LP | 1.8% | -77% | $99,699,331 | -$263,401,363 | 2,802,905 | -73% | Commodore Capital LP | 31 Dec 2025 |
As of 31 Mar 2026, 303 institutional investors reported holding 186,329,144 shares of Cogent Biosciences, Inc. - Common Stock (COGT). This represents 109% of the company’s total 170,962,250 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
77%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 14% | 23,122,748 | +0.15% | 0.05% | $889,994,587 |
| BlackRock, Inc. | 9.4% | 16,045,014 | +24% | 0.01% | $617,572,589 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 5.3% | 9,043,903 | 0% | 4.1% | $348,099,826 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.3% | 7,333,333 | 0% | 0.01% | $282,259,987 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 6,894,959 | 0% | 0.01% | $265,386,972 |
| JANUS HENDERSON GROUP PLC | 3.5% | 5,965,125 | +31% | 0.11% | $229,633,788 |
| STATE STREET CORP | 3.3% | 5,663,543 | +15% | 0.01% | $217,989,770 |
| Fairmount Funds Management LLC | 3.2% | 5,503,418 | -39% | 15% | $211,826,559 |
| RTW INVESTMENTS, LP | 3.2% | 5,458,675 | -28% | 2.1% | $210,104,401 |
| TCG Crossover Management, LLC | 2.9% | 4,946,894 | -16% | 5.4% | $190,405,950 |
| GOLDMAN SACHS GROUP INC | 2.6% | 4,434,054 | +160% | 0.02% | $170,666,738 |
| Kynam Capital Management, LP | 2.4% | 4,037,331 | -35% | 9.9% | $155,396,870 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 3,699,519 | +5.3% | 0.01% | $142,424,832 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.1% | 3,578,622 | +32% | 0.03% | $137,741,160 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.9% | 3,212,815 | +25% | 0.01% | $123,662,000 |
| LORD, ABBETT & CO. LLC | 1.9% | 3,181,270 | +70% | 0.4% | $122,447,000 |
| Commodore Capital LP | 1.7% | 2,888,007 | +31% | 6.4% | $111,159,389 |
| Invesco Ltd. | 1.4% | 2,429,629 | +315% | 0.01% | $93,516,420 |
| Octagon Capital Advisors LP | 1.4% | 2,350,000 | 0% | 10% | $90,451,500 |
| Holocene Advisors, LP | 1.3% | 2,250,196 | +91% | 0.21% | $86,610,044 |
| Sofinnova Investments, Inc. | 1.2% | 2,113,551 | +7.1% | 4.1% | $81,350,578 |
| Venrock Adviser, LLC | 1.2% | 2,000,000 | 0% | 2.9% | $76,980,000 |
| D. E. Shaw & Co., Inc. | 1.1% | 1,868,389 | -17% | 0.06% | $71,914,293 |
| Pictet Asset Management Holding SA | 1.1% | 1,798,768 | +1499% | 0.07% | $68,825,910 |
| CITADEL ADVISORS LLC | 1% | 1,714,927 | +19% | 0.05% | $66,007,540 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
22
Latest
Q1 2026
Rows shown
1-22 of 22
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 186,329,144 | $7,169,925,579 | +$317,717,543 | $38.49 | 303 |
| 2025 Q4 | 174,084,958 | $6,184,105,170 | +$561,964,697 | $35.52 | 266 |
| 2025 Q3 | 159,224,831 | $2,286,403,568 | +$377,675,482 | $14.36 | 192 |
| 2025 Q2 | 135,519,487 | $973,045,860 | +$18,987,122 | $7.18 | 175 |
| 2025 Q1 | 133,492,788 | $799,614,961 | +$57,857,622 | $5.99 | 182 |
| 2024 Q4 | 121,716,056 | $949,488,255 | -$21,661,319 | $7.80 | 173 |
| 2024 Q3 | 121,834,182 | $1,316,352,629 | +$470,587 | $10.80 | 160 |
| 2024 Q2 | 121,381,737 | $1,023,259,146 | +$106,597,224 | $8.43 | 146 |
| 2024 Q1 | 109,208,822 | $733,878,161 | +$128,257,287 | $6.72 | 144 |
| 2023 Q4 | 90,814,821 | $533,992,647 | -$45,403,172 | $5.88 | 141 |
| 2023 Q3 | 90,861,393 | $885,844,189 | +$20,538,646 | $9.75 | 134 |
| 2023 Q2 | 88,529,694 | $1,048,151,896 | +$158,614,636 | $11.84 | 134 |
| 2023 Q1 | 75,176,767 | $810,346,243 | +$3,226,883 | $10.79 | 133 |
| 2022 Q4 | 74,675,712 | $863,268,307 | -$1,804,375 | $11.56 | 133 |
| 2022 Q3 | 73,734,143 | $1,100,096,408 | +$70,755,840 | $14.92 | 129 |
| 2022 Q2 | 70,081,829 | $632,136,824 | +$209,072,563 | $9.02 | 107 |
| 2022 Q1 | 47,217,562 | $353,580,440 | -$5,659,624 | $7.49 | 81 |
| 2021 Q4 | 44,899,168 | $385,164,997 | +$41,807,073 | $8.58 | 80 |
| 2021 Q3 | 36,797,124 | $309,606,147 | +$4,142,169 | $8.41 | 71 |
| 2021 Q2 | 34,971,040 | $283,623,000 | +$12,872,399 | $8.11 | 65 |
| 2021 Q1 | 34,431,767 | $303,253,000 | +$9,820,126 | $8.78 | 65 |
| 2020 Q4 | 33,524,756 | $376,481,000 | +$318,450,000 | $11.23 | 67 |